CALCIUM TRANSPORT PATHWAY (PW:0001139)
Description
Calcium permeates almost every aspect of cellular processes and the pathways associated with them - from proliferation to cell death, contraction and gene expression, hormone and neurotransmitter release, metabolism and synaptic plasticity. Movement of calcium ions in and outside of the cell is paramount to the maintenance of a calcium gradient four order of magnitudes between the extracellular environment and the cytoplasmic concentration of resting cells. The steep gradient allows for fast local increases in cytoplasmic concentration that underlie the broad range of cellular functions mediated by calcium signaling. A large array of channels at the plasma membrane or the endoplasmic/sarcoplasmic reticulum (ER/SR) mediates calcium entry or release into the cytoplasm; all activated by a variety of stimuli and ligands and in the case of ER/SR channels by calcium itself, also referred to as calcium initiated calcium release (CICR). Extending this initial input, characterized as 'puff', 'blip', 'spark' or 'wave' depending on its spatiotemporal features, a broad spectrum of calcium sensors further carry out the calcium signaling tasks. The increase in calcium ion concentration is transient to prevent its possible toxic effect; in high amount, Ca2+ can aggregate nucleic acids and proteins or impact on the integrity of lipid membranes. Extrusion of calcium ions outside the cell or back into ER/SR is carried out by ATP dependent pumps and exchangers, effectively regulating the calcium signal. Calcium buffers also help maintain the relatively low, ~100nM free calcium concentration of the resting cell. Channels, pumps and exchangers mediating the movement of calcium in and out of cells and organelles control the balance between the provision of the signal and its timely removal; they are shown in the generic diagram and briefly described. As integral components of the 'calcium signaling kit', they are also present in the calcium/calcium-mediated signaling interactive pathway diagram -
click here to access it directly ,
(or on the diagram to get to its ontology report).
Prominent players are the voltage operated or voltage-gated, calcium channels (VOCs); they are activated by changes in membrane potential and the flow of calcium initiates signaling events controlling many cellular processes in both excitable and non-excitable cells. In cardiac and muscle cells, calcium entry mediates contraction and also prompts CICR from intracellular stores; in neurons and endocrine cells, it initiates synaptic transmission and hormone release, respectively. Structurally, they are multi-subunit complexes of which alpha is the pore forming subunit and the beta, gamma or delta are ancillary. The alpha subunits differ by the type of Ca2+ currents and can be subdivided into three subfamilies of which the L-type channels are better characterized. The alpha subunit is subject to processing and post-translational modifications that modulate its function. Modulators include Ca2+ sensors and effectors such as calmodulin (CaM), the rather universal Ca2+ sensor.
Transient receptor potential channels (TRPs), when activated depolarize the membrane leading to flow of Na+ and Ca2+ ions into the cell. Overall, the TRP channels are weakly voltage sensitive and mostly nonselective ion channels. The rather large family is subdivided into several subfamilies; Ca2+ selectivity appears to be confined to a subgroup of the 'vanilloid' TRPV family. A member of the mucolipin family, Mcoln1 known as TRPML1, is a Ca2+ and Fe2+ release channel located in lysosomes and late endosomes. Cyclic nucleotide gated channels (CNGs) respond to changes in the intracellular concentration of cGMP and also cAMP to increase Ca2+ concentration in photoreceptor and olfactory cells. Store operated (ORAIs) channels represent a special class as they are not activated by extracellular stimuli but by reduction of calcium in ER with the Stim proteins playing a central role. In the resting state, the EF-hand containing calcium sensor proteins are located in the ER; upon Ca2+ depletion and dissociation of the ion from the EF-hand domain, the proteins oligomerize, translocate to ER-plasma membrane junctions where they couple to and activate the channels. Finally, transmitter/small molecule (acetylcholine, glutamate, ATP) gated ion channels (eg AMPA, NMDA, purinergic) or receptor operated channels (ROCs) are permeable to Ca2+ and other ions and function in neuron-to-neuron signaling, learning, memory and synaptic plasticity, among others; their detailed description is beyond the scope of this synopsis. The link provides a brief description and selected references; they will be individually presented in the context of neurotransmitters/small molecule signaling pathways with which they are associated.
Signaling via G-protein coupled (GPCR) or tyrosine kinase (TKR) receptors leads to generation of inositol 1,4,5,-trisphosphate (IP3) and diacylglycerol (DAG) second messengers. IP3 binds IP3 receptors (ITPRs) in ER to prompt, along with Ca2+ , the release of the ion from ER stores. The functional receptor is a tetramer and in higher organisms, diversity is achieved by the presence of three genes, their splice variants and the possible formation of both homo- and heterotetramers. Phosphorylation and dephosphorylation events and interaction with other partners, in turn subject to phosphorylation/dephosphorylation regulation, modulate their activity. Ahcyl1, known as IRBIT, and the anti-apoptotic Bcl2 are important partners; phosphorylated Ahcyl1 binds to the receptor to a site overlapping the IP3 site and inhibits the receptor by competing with IP3 binding. IRBIT has roles beyond ITPR regulation, such as the control of epithelial fluid and bicarbonate secretion. In a similar fashion Ca2+ and cyclic ADP ribose (cADPr) activate the ryanodine receptors (RYRs) to prompt Ca2+ release from SR stores during excitation-contraction coupling in both cardiac and skeletal muscle. Of note is that in skeletal muscle Ryr1 is in physical contact with the Cacna1s (Cav1.1) channel leading to 'voltage-induced' Ca2+ release; in cardiac muscle, Ryr2 mediated Ca2+ release is initiated in response to Ca2+ influx via Cacna1c(Cav1.2), or CICR. The receptors, which are represented by three genes, are homotetramers and are found in protein complexes with several partners that exert various effects; they include Ca2+ buffers such as calsequestrins or stabilizing proteins such as calstabins, among others. The Ca2+ sensor CaM acts as a partial agonist in its apo- (Ca2+ free) form whereas the Ca2+-bound CaM acts as an inhibitor. Mutations in RYR1 and 2 are associated with a number of human diseases. Both the ITPRs and RYRs are large molecules with RYRs being the largest; both possess Ca2+ binding sites that differ in their affinity for and which mediate the stimulatory or inhibitory effect of the metal ion.
Pumps are P-type ATPases that use the energy of ATP to transport Ca2+ outside the cell or back into the ER/SR against its concentration gradient. They exchange protons for two or one Ca2+ pumped into ER/SR or outside the cell, per ATP hydrolyzed, respectively; there are two Ca2+ binding sites in SERCA pumps whereas the plasma membrane PMCA pumps have one. There are three ER/SR (SERCAs, ATP2A1-3) and four plasma membrane (PMCAs, ATP2B1-4) pumps. Other pumps are represented by the Golgi ATPases (SPCA, ATP2C1 and 2) which also transport Mn2+, a feature that probably relates to the Mn2+ requiring enzymes in the lumen of Golgi, such as the glycosyltransferases.
Another mechanism for Ca2+ extrusion outside the cell involves exchangers: the Na+/Ca2+ exchangers (NCX or SLC8A1-3) and the Na+/Ca2+ -K+ exchangers (NCKX or SLC24A1-5) exchange one Ca2+ for three Na+ ions or co-transport one Ca2+ and one K+ in exchange for four Na+, respectively.
In the mitochondria, the uptake of Ca2+ is favored by the electrochemical proton gradient the electron transport chain pathway generates and is mediated by the Mcu mitochondrial uniporter complex - a selective channel that moves the ion across the mitochondrial inner membrane. In the opposite direction, a Na+/Li+/ Ca2+ exchanger (Slc24a6) promotes release of the metal ion. Nicotinic acid adenine dinucleotide phosphate (NAADP)-gated calcium channels, the two-pore segment channels represented by the two members in humans (TPCN1 and 2) and rodents in the family of three in most other mammals, mediate Ca2+ release from acidic stores in endosomic/lysosomic compartments. Whether TPCNs and perhaps ryanodine channels directly bind NAADP or binding is mediated by some other intermediary protein, is not yet a fully settled issue. The identity of the uptake mechanism in the acidic stores has not been elucidated; a putative Ca2+/H+ exchanger has been postulated. Of note is the fact that in mammalian cells, a multifunctional ATP ribosyl cyclase can generate NAADP or cADPr depending on whether the cofactor used is NADP or NAD, respectively.
Channels activated by/responding to increase in intracellular Ca2+ such as members of the potassium or chloride channels are not part of this balanced gradient control and are not shown; likewise not shown are buffers which do play a role but are not involved in calcium transport/movement. These molecules are responders and modulators of calcium signaling, respectively and along with sensors and other players will be presented in the context of calcium/calcium-mediated signaling.
The movement of calcium ion in and out of cells and organelles, the regulated availability of the free metal ion and the interaction with its many sensors, the calcium transport and calcium-mediated signaling pathways are inextricably connected. Together, they are the components of the 'calcium signaling kit' and together, they orchestrate the homeostasis of what is probably the most versatile element in the kingdoms of life. To see the ontology report for annotations, Gviewer and download, click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Atp2a1
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr12:34,072,710...34,122,142
Ensembl chr12:34,072,683...34,122,101
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:33,735,871...33,843,295
G
Atp2b2
ATPase plasma membrane Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 4:146,894,602...147,208,060
Ensembl chr 4:146,896,332...147,140,665
G
Atp2b3
ATPase plasma membrane Ca2+ transporting 3
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775
G
Atp2b4
ATPase plasma membrane Ca2+ transporting 4
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246
G
Atp2c1
ATPase secretory pathway Ca2+ transporting 1
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006
G
Atp2c2
ATPase secretory pathway Ca2+ transporting 2
ISO
RGD
PMID:19789383
RGD:7204695
NCBI chr19:47,754,120...47,811,369
Ensembl chr19:47,754,120...47,811,368
G
Cacna1a
calcium voltage-gated channel subunit alpha1 A
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
G
Cacna1b
calcium voltage-gated channel subunit alpha1 B
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091
G
Cacna1c
calcium voltage-gated channel subunit alpha1 C
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cacna1e
calcium voltage-gated channel subunit alpha1 E
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr13:66,574,659...67,063,443
Ensembl chr13:66,581,920...66,894,450
G
Cacna1f
calcium voltage-gated channel subunit alpha1 F
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr X:14,868,096...14,896,413
Ensembl chr X:14,868,024...14,896,413
G
Cacna1g
calcium voltage-gated channel subunit alpha1 G
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Cacna1i
calcium voltage-gated channel subunit alpha1 I
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 7:111,835,996...111,947,418
Ensembl chr 7:111,836,012...111,944,688
G
Cacna1s
calcium voltage-gated channel subunit alpha1 S
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318
G
Cacnb1
calcium voltage-gated channel auxiliary subunit beta 1
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr10:82,998,182...83,018,838
Ensembl chr10:82,998,182...83,018,694
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Cacnb3
calcium voltage-gated channel auxiliary subunit beta 3
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 7:129,784,799...129,797,074
Ensembl chr 7:129,783,674...129,797,074
G
Cacnb4
calcium voltage-gated channel auxiliary subunit beta 4
ISO
RGD
PMID:21746798
RGD:7204688
NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944
G
Cnga1
cyclic nucleotide gated channel subunit alpha 1
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr14:35,566,947...35,605,065
Ensembl chr14:35,567,125...35,605,065
G
Cnga2
cyclic nucleotide gated channel subunit alpha 2
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr X:149,696,999...149,715,051
Ensembl chr X:149,696,997...149,715,051
G
Cnga3
cyclic nucleotide gated channel subunit alpha 3
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr 9:39,447,534...39,494,044
Ensembl chr 9:39,448,034...39,493,183
G
Cnga4
cyclic nucleotide gated channel subunit alpha 4
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr 1:159,752,357...159,756,369
Ensembl chr 1:159,752,357...159,756,375
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
TAS
RGD
PMID:12087135
RGD:6893549
NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173
G
Cngb3
cyclic nucleotide gated channel subunit beta 3
ISO
RGD
PMID:12087135
RGD:6893549
NCBI chr 5:32,746,988...32,995,121
Ensembl chr 5:32,746,988...32,995,121
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
ISO
RGD
PMID:19133301
RGD:7204693
NCBI chr20:5,136,968...5,202,339
Ensembl chr20:5,136,441...5,202,337
G
Mcoln1
mucolipin TRP cation channel 1
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr12:1,560,341...1,574,252
Ensembl chr12:1,560,359...1,574,252
G
Mcu
mitochondrial calcium uniporter
ISO
RGD
PMID:22850819
RGD:7204696
NCBI chr20:27,417,529...27,580,110
Ensembl chr20:27,417,526...27,580,110
G
Orai1
ORAI calcium release-activated calcium modulator 1
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr12:33,533,151...33,548,361
Ensembl chr12:33,534,344...33,548,405
G
Orai2
ORAI calcium release-activated calcium modulator 2
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr12:20,500,308...20,520,428
Ensembl chr12:20,497,317...20,520,428
G
Orai3
ORAI calcium release-activated calcium modulator 3
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr 1:182,381,196...182,386,055
Ensembl chr 1:182,344,293...182,386,052
G
Ryr1
ryanodine receptor 1
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
Ryr2
ryanodine receptor 2
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr17:58,389,925...58,975,641
Ensembl chr17:58,389,925...58,975,142
G
Ryr3
ryanodine receptor 3
ISO
RGD
PMID:20961976
RGD:7204694
NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:99,432,505...99,704,961
G
Slc24a1
solute carrier family 24 member 1
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 8:65,440,842...65,466,001
Ensembl chr 8:65,440,730...65,466,001
G
Slc24a2
solute carrier family 24 member 2
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 5:101,497,916...101,741,840
Ensembl chr 5:101,502,278...101,739,337
G
Slc24a3
solute carrier family 24 member 3
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 3:132,552,119...133,051,192
Ensembl chr 3:132,551,595...133,051,192
G
Slc24a4
solute carrier family 24 member 4
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:121,279,590...121,419,811
Ensembl chr 6:121,280,031...121,414,949
G
Slc24a5
solute carrier family 24 member 5
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 3:112,319,349...112,338,889
Ensembl chr 3:112,319,308...112,339,231
G
Slc8a1
solute carrier family 8 member A1
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc8a2
solute carrier family 8 member A2
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 1:76,816,583...76,852,928
Ensembl chr 1:76,808,725...76,847,072
G
Slc8a3
solute carrier family 8 member A3
ISO
RGD
PMID:17716241
RGD:7204698
NCBI chr 6:100,874,359...101,007,989
Ensembl chr 6:100,874,369...101,007,508
G
Slc8b1
solute carrier family 8 member B1
ISO
RGD
PMID:22850819
RGD:7204696
NCBI chr12:36,029,759...36,053,087
Ensembl chr12:36,029,760...36,053,031
G
Stim1
stromal interaction molecule 1
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
G
Stim2
stromal interaction molecule 2
ISO
RGD
PMID:22914293
RGD:7204692
NCBI chr14:56,878,428...57,004,405
Ensembl chr14:56,878,645...57,004,179
G
Tpcn1
two pore segment channel 1
ISO
RGD
PMID:20018950
RGD:7204697
NCBI chr12:35,972,813...36,029,632
Ensembl chr12:35,972,846...36,029,626
G
Tpcn2
two pore segment channel 2
ISO
RGD
PMID:20018950
RGD:7204697
NCBI chr 1:200,416,538...200,446,252
Ensembl chr 1:200,416,540...200,446,236
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:70,536,440...70,562,745
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
ISO
RGD
PMID:20716668
RGD:7204689
NCBI chr 4:70,507,347...70,523,013
Ensembl chr 4:70,507,348...70,523,017
Pathway Gene Annotations
Disease Annotations Associated with Genes in the calcium transport pathway
Atp2a1 Alcohol Myopathy , Brody myopathy , Cachexia , chromosome 16p11.2 deletion syndrome, 220-kb , chromosome 16p11.2 deletion syndrome, 593-kb , congestive heart failure , dilated cardiomyopathy , Experimental Diabetes Mellitus , genetic disease , Myocardial Reperfusion Injury , neuronal ceroid lipofuscinosis , schizophrenia , Sepsis , Spinal Cord Injuries , type 2 diabetes mellitus Atp2a2 abdominal obesity-metabolic syndrome 1 , acrokeratosis verruciformis , Acute Experimental Pancreatitis , Cachexia , Cardiomegaly , congestive heart failure , Darier Disease, Acral Hemorrhagic Type , Darier Disease, Segmental , Diabetic Cardiomyopathies , essential hypertension , euthyroid sick syndrome , Experimental Diabetes Mellitus , genetic disease , heart disease , hypothyroidism , Iron Overload , keratosis follicularis , Myocardial Reperfusion Injury , myocardial stunning , Neointima , pulmonary hypertension , Spinal Cord Injuries , status epilepticus , type 2 diabetes mellitus , Ventricular Dysfunction, Left , Ventricular Tachycardia Atp2a3 adenoma , Experimental Diabetes Mellitus , hypertension , type 2 diabetes mellitus Atp2b1 autistic disorder , autosomal dominant intellectual developmental disorder 30 , Autosomal Dominant Intellectual Developmental Disorder 66 , cataract , clubfoot , coronary artery disease , genetic disease , gestational diabetes , hypertension , Neurodevelopmental Disorders , pre-eclampsia Atp2b2 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome , agenesis of the corpus callosum with peripheral neuropathy , Atrioventricular Septal Defect 2 , autosomal dominant nonsyndromic deafness , autosomal dominant nonsyndromic deafness 82 , autosomal recessive nonsyndromic deafness 12 , brain infarction , Generalized Epilepsy , gestational diabetes , Hearing Loss , Myoclonic Epilepsies , myoclonic-atonic epilepsy , Neurodevelopmental Disorders , pre-eclampsia Atp2b3 adenoma , adrenal cortical adenoma , adrenoleukodystrophy , autistic disorder , autosomal hemophilia A , Barth syndrome , cerebral creatine deficiency syndrome 1 , Developmental Disabilities , dyskeratosis congenita , Emery-Dreifuss muscular dystrophy , factor VIII deficiency , favism , fetal akinesia deformation sequence syndrome 1 , genetic disease , gestational diabetes , hypertension , immunodeficiency 33 , Meester-Loeys syndrome , Muscle Hypotonia , Neurodevelopmental Disorders , paraplegia , periventricular nodular heterotopia , pre-eclampsia , primary hyperaldosteronism , severe congenital encephalopathy due to MECP2 mutation , spastic ataxia , Splenomegaly , syndromic X-linked intellectual disability Lubs type , thoracic aortic aneurysm , Tremor , X-linked spinocerebellar ataxia 1 Atp2b4 dystonia , familial adult myoclonic epilepsy 5 , gastrointestinal stromal tumor , gestational diabetes , Hypokalemic Periodic Paralysis, Type 1 , parathyroid carcinoma , pre-eclampsia , prostate cancer Atp2c1 alkaptonuria , genetic disease , Hailey-Hailey disease , immunodeficiency 21 , Primary Lymphedema with Myelodysplasia Atp2c2 persistent fetal circulation syndrome Cacna1a Aicardi-Goutieres Syndrome 4 , alpha-mannosidosis , amyotrophic lateral sclerosis , Ataxia , attention deficit hyperactivity disorder , Auditory Neuropathy , autism spectrum disorder , autistic disorder , bone marrow disease , cerebellar ataxia , cerebral palsy , cerebral venous thrombosis , Charcot-Marie-Tooth disease dominant intermediate B , childhood absence epilepsy , childhood electroclinical syndrome , combined immunodeficiency , combined T cell and B cell immunodeficiency , developmental and epileptic encephalopathy 1 , developmental and epileptic encephalopathy 2 , developmental and epileptic encephalopathy 42 , developmental and epileptic encephalopathy 52 , Developmental Disabilities , disorder of sexual development , Dysarthria , epilepsy , episodic ataxia , episodic ataxia type 2 , exfoliation syndrome , familial hemiplegic migraine , familial hemiplegic migraine 1 , generalized dystonia , Generalized Epilepsy , genetic disease , glutaric acidemia I , intellectual disability , Lambert-Eaton myasthenic syndrome , learning disability , Marshall-Smith syndrome , migraine , migraine with aura , Muscle Spasticity , Muscle Weakness , myelitis , myoclonic-atonic epilepsy , Nervous System Malformations , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , neurogenic bladder , Neurologic Gait Disorders , progressive bulbar palsy , spastic ataxia , Spastic Paraparesis , spinocerebellar ataxia type 6 , Spinocerebellar Ataxias , Sporadic Hemiplegic Migraine , subependymal giant cell astrocytoma , sudden infant death syndrome , temporal lobe epilepsy , Tremor , vascular dementia Cacna1b Adams-Oliver Syndrome 5 , autosomal dominant intellectual developmental disorder 8 , brain edema , developmental and epileptic encephalopathy 14 , Diabetic Nephropathies , dystonia 23 , epilepsy , Experimental Autoimmune Encephalomyelitis , Hyperalgesia , Joubert syndrome 1 , Kleefstra syndrome 1 , Lambert-Eaton myasthenic syndrome , multiple sclerosis , Neurodevelopmental Disorder with Seizures and Nonepileptic Hyperkinetic Movements , peripheral nervous system disease , primary coenzyme Q10 deficiency 7 , Rafiq syndrome Cacna1c acute stress disorder , alcohol dependence , Alzheimer's disease , amyloidosis , anxiety disorder , arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , autistic disorder , bipolar disorder , breast ductal carcinoma , Brugada syndrome , Brugada syndrome 3 , Cardiac Arrhythmias , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , cerebral palsy , Cognitive Dysfunction , Congenital Limb Deformities , congestive heart failure , dilated cardiomyopathy , epilepsy , esophageal atresia , Familial Ventricular Tachycardia , Fetal Growth Retardation , genetic disease , Genetic Predisposition to Disease , Heart Block , Hyperphosphatemic Familial Tumoral Calcinosis 1 , hypertension , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypoglycemia , intellectual disability , invasive ductal carcinoma , Joint Instability , Language Development Disorders , long QT syndrome , long QT syndrome 1 , long QT syndrome 8 , major depressive disorder , neurodevelopmental disorder with dysmorphic facies and distal limb anomalies , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , post-traumatic stress disorder , primary immunodeficiency disease , Psychomotor Agitation , pulmonary valve stenosis , restrictive cardiomyopathy , Romano-Ward Syndrome , schizophrenia , short QT syndrome , Sudden Cardiac Death , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Timothy syndrome , Tremor , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Cacna1d adenoma , Alcohol Withdrawal Seizures , Animal Disease Models , autism spectrum disorder , bipolar disorder , Bradycardia , colon adenocarcinoma , colon adenoma , congenital disorder of glycosylation Iw , Deafness , Drug-Induced Dyskinesia , epilepsy , Fetal Growth Retardation , genetic disease , Hearing Loss , Heart Block , intellectual disability , long QT syndrome , Memory Disorders , Meniere's disease , Presbycusis , Primary Aldosteronism, Seizures, and Neurologic Abnormalities , primary hyperaldosteronism , prostate cancer , sciatic neuropathy , sick sinus syndrome , Sinoatrial Node Dysfunction and Deafness , Supraventricular Tachycardia , type 2 diabetes mellitus Cacna1e 1q24 Deletion Syndrome , autosomal recessive chronic granulomatous disease 2 , Coma , developmental and epileptic encephalopathy , developmental and epileptic encephalopathy 69 , early infantile epileptic encephalopathy , gastrointestinal stromal tumor , genetic disease , hyperglycemia , intellectual disability , parathyroid carcinoma , Van der Woude syndrome , Wolff-Parkinson-White syndrome Cacna1f Aland Island eye disease , autistic disorder , cone-rod dystrophy , congenital disorder of glycosylation type IIm , congenital stationary night blindness , congenital stationary night blindness 2A , Eye Abnormalities , fundus dystrophy , genetic disease , immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome , macular degeneration , myopia , neurodegeneration with brain iron accumulation 5 , retinitis pigmentosa , syndromic X-linked intellectual disability Lubs type , Thrombocytopenia 1 , Wiskott-Aldrich syndrome , X-linked cone-rod dystrophy 3 , X-linked epilepsy with variable learning disabilities and behavior disorders , X-linked severe congenital neutropenia Cacna1g brain disease , cerebellar ataxia , cerebellar ataxia type 42 , Developmental Disease , epilepsy , genetic disease , hereditary breast ovarian cancer syndrome , intellectual disability , juvenile myoclonic epilepsy , Left Ventricular Hypertrophy , nephrotoxicity , Neurodevelopmental Disorders , spastic ataxia , Spinocerebellar Ataxia 42, Early-Onset, Severe, with Neurodevelopmental Deficits , Spinocerebellar Ataxias , trichodontoosseous syndrome Cacna1h arteriovenous malformations of the brain , autistic disorder , beta thalassemia , breast ductal carcinoma , childhood absence epilepsy , Childhood Absence Epilepsy 6 , Drug-Related Side Effects and Adverse Reactions , epilepsy , Familial Hyperaldosteronism, Type IV , focal epilepsy , genetic disease , Hyperalgesia , idiopathic generalized epilepsy , invasive ductal carcinoma , peripheral nervous system disease , primary hyperaldosteronism , sciatic neuropathy , short-rib thoracic dysplasia 9 with or without polydactyly , tuberous sclerosis 2 Cacna1i adenylosuccinase lyase deficiency , Developmental Disabilities , hydrocephalus , Hyperalgesia , long QT syndrome , Neurodevelopmental Disorder with Speech Impairment and with or without Seizures , Rubinstein-Taybi syndrome , schizophrenia , sciatic neuropathy , Ventriculomegaly , withdrawal disorder Cacna1s centronuclear myopathy , congenital myopathy 18 , familial adult myoclonic epilepsy 5 , gastrointestinal stromal tumor , genetic disease , hereditary neuropathy with liability to pressure palsies , hypokalemic periodic paralysis , Hypokalemic Periodic Paralysis, Type 1 , long QT syndrome , Malignant Fever , malignant hyperthermia , muscular atrophy , nephrotoxicity , parathyroid carcinoma , respiratory failure , Rhabdomyolysis , Sepsis , Thyrotoxic Periodic Paralysis Cacnb2 arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , Brugada syndrome , Brugada syndrome 4 , cardiac arrest , Cardiac Arrhythmias , cardiomyopathy , dilated cardiomyopathy , heart conduction disease , hypertension , hypertrophic cardiomyopathy , hypoparathyroidism-deafness-renal disease syndrome , Imerslund-Grasbeck Syndrome , long QT syndrome , Nerve Injuries , Paroxysmal Ventricular Fibrillation , short QT syndrome , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Supraventricular Tachycardia , Ventricular Fibrillation , Ventricular Tachycardia Cacnb3 Kabuki syndrome , Nerve Injuries , ovarian cyst Cacnb4 Ataxia , dilated cardiomyopathy , episodic ataxia , episodic ataxia type 5 , Generalized Epilepsy , idiopathic generalized epilepsy , idiopathic generalized epilepsy 9 , juvenile myoclonic epilepsy , nemaline myopathy 2 , spastic ataxia Cnga1 cone-rod dystrophy , fundus dystrophy , genetic disease , macular degeneration , prostate cancer , retinitis pigmentosa , retinitis pigmentosa 49 Cnga2 autistic disorder , autosomal hemophilia A , factor VIII deficiency , syndromic X-linked intellectual disability Lubs type Cnga3 achromatopsia , Achromatopsia 1 , achromatopsia 2 , color blindness , cone dystrophy , cone-rod dystrophy , Eye Abnormalities , fundus dystrophy , genetic disease , macular degeneration Cnga4 neuronal ceroid lipofuscinosis Cngb1 Bardet-Biedl syndrome , Chromosome 16q12 Duplication Syndrome , developmental and epileptic encephalopathy , early infantile epileptic encephalopathy , fundus dystrophy , genetic disease , retinitis pigmentosa , retinitis pigmentosa 45 , retinitis pigmentosa 49 Cngb3 achromatopsia , Achromatopsia 1 , achromatopsia 3 , color blindness , cone-rod dystrophy , Eye Abnormalities , fundus dystrophy , genetic disease , globe disease , Leber congenital amaurosis , macular degeneration , pathologic nystagmus , retinitis pigmentosa , Stargardt disease , Stargardt Disease 1 Itpr1 Alzheimer's disease , anterior segment dysgenesis , asthma , Ataxia , autosomal dominant cerebellar ataxia , Brain Hypoxia , cardiac arrest , cerebellar ataxia , Chemical and Drug Induced Liver Injury , Congenital Mydriasis , diabetes mellitus , dilated cardiomyopathy , epilepsy , genetic disease , gestational diabetes , Gillespie syndrome , Huntington's disease , Hyperalgesia , Hypoxia , intellectual disability , movement disease , mucosulfatidosis , nephrotoxicity , neurodegenerative disease , Neurodevelopmental Disorders , Niemann-Pick disease type A , pre-eclampsia , Prostatic Neoplasms , spastic ataxia , spinocerebellar ataxia type 15 , spinocerebellar ataxia type 29 , Spinocerebellar Ataxias , transient cerebral ischemia Itpr2 amyotrophic lateral sclerosis , Brain Hypoxia , Cardiomegaly , gestational diabetes , intellectual disability , isolated anhidrosis with normal sweat glands , pre-eclampsia Itpr3 acrodermatitis , Animal Disease Models , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder 5 , Charcot-Marie-Tooth Disease Type 1J , gestational diabetes , long QT syndrome , pre-eclampsia , proteasome-associated autoinflammatory syndrome 1 , type 1 diabetes mellitus Mcoln1 acute kidney failure , Boucher-Neuhauser syndrome , Corneal Opacity , familial hemophagocytic lymphohistiocytosis 5 , genetic disease , glycoproteinosis , Growth Disorders , hereditary spastic paraplegia , hereditary spastic paraplegia 39 , hereditary spastic paraplegia 5A , intellectual disability , Lisch epithelial corneal dystrophy , mucolipidosis , mucolipidosis type IV , Nervous System Malformations , periventricular leukomalacia Orai1 congenital structural myopathy , genetic disease , hypertension , immunodeficiency 9 , Neoplasm Metastasis , short chain acyl-CoA dehydrogenase deficiency , Tubular Aggregate Myopathies , tubular aggregate myopathy 1 , tubular aggregate myopathy 2 Orai2 pleomorphic xanthoastrocytoma Orai3 branched-chain keto acid dehydrogenase kinase deficiency , dilated cardiomyopathy , generalized epilepsy with febrile seizures plus 9 Ryr1 ankyloglossia , anterior segment dysgenesis , anterior segment dysgenesis 7 , Aortic Coarctation , arthrogryposis multiplex congenita , atrial heart septal defect , autosomal dominant intellectual developmental disorder 26 , Axial Myopathy, Late-Onset , Bronchomalacia , cardiomyopathy , caudal regression syndrome , centronuclear myopathy , clubfoot , Congenital Hip Dislocation , congenital muscular dystrophy , congenital myasthenic syndrome , congenital myasthenic syndrome 12 , congenital myopathy , congenital myopathy 1A , congenital myopathy 1B , congenital myopathy 4A , Congenital Neuromuscular Disease, with Uniform Type 1 Fiber , congenital structural myopathy , congestive heart failure , Developmental Disabilities , distal arthrogryposis , Dwarfism , Dyskinesias , dystonia , fetal akinesia deformation sequence syndrome , fetal akinesia deformation sequence syndrome 1 , gastroesophageal reflux disease , genetic disease , gestational diabetes , glaucoma , GNE myopathy , Heart Block , Heat Stroke , hereditary nonpolyposis colorectal cancer type 5 , Hydrops Fetalis , intracranial vasospasm , isolated elevated serum creatine phosphokinase levels , King Denborough syndrome , Lead Poisoning , learning disability , Left Ventricular Hypertrophy , long QT syndrome , Malignant Fever , malignant hyperthermia , Malignant Hypothermia , Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay , Muscle Hypotonia , muscle tissue disease , Muscle Weakness , Myalgia , myocardial infarction , myopathy , Myotonia , nephrotoxicity , neuromuscular disease , obesity , obstructive sleep apnea , osteochondrodysplasia , osteogenesis imperfecta type 1 , osteoporosis , panhypopituitarism , pre-eclampsia , primary pulmonary hypertension , ptosis , pulmonary hypertension , renal cell carcinoma , respiratory failure , Rhabdomyolysis , rigid spine muscular dystrophy 1 , scoliosis , Sepsis , Spinal Cord Injuries , Uncombable Hair Syndrome 1 , ventricular septal defect Ryr2 arrhythmogenic right ventricular cardiomyopathy , arrhythmogenic right ventricular dysplasia 1 , arrhythmogenic right ventricular dysplasia 9 , autism spectrum disorder , Brugada syndrome , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 2 , Childhood Schizophrenia , congenital heart disease , congestive heart failure , coronary artery disease , Diabetic Cardiomyopathies , Diastolic Dysfunction , dilated cardiomyopathy , dilated cardiomyopathy 1AA , dilated cardiomyopathy 1B , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Experimental Diabetes Mellitus , familial hypertrophic cardiomyopathy , Familial Sudden Death , Familial Ventricular Tachycardia , gastrointestinal stromal tumor , gestational diabetes , Heart Block , heart disease , Hereditary Leiomyomatosis and Renal Cell Cancer , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypertrophic cardiomyopathy 4 , Infant Death , Leber congenital amaurosis , left ventricular noncompaction , long QT syndrome , long QT syndrome 1 , malignant mesothelioma , Myocardial Ischemia , parathyroid carcinoma , Paroxysmal Ventricular Fibrillation , pre-eclampsia , pulmonary hypertension , Sudden Cardiac Death , Sudden Death , Syncope , Tachycardia , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Ryr3 amenorrhea , arthrogryposis multiplex congenita , Bloom syndrome , colorectal cancer , congenital myopathy 20 , Contracture , developmental and epileptic encephalopathy , epilepsy , fetal akinesia deformation sequence syndrome 1 , Generalized Epilepsy , genetic disease , gestational diabetes , hepatocellular carcinoma , Hydrops Fetalis , Monomelic Amyotrophy , pre-eclampsia , primary ovarian insufficiency , pulmonary hypertension Slc24a1 Bloom syndrome , Cerebral Hemorrhage , colorectal cancer , congenital stationary night blindness , congenital stationary night blindness 1D , congenital stationary night blindness autosomal dominant 2 , fundus dystrophy , genetic disease , nemaline myopathy 6 , retinitis pigmentosa Slc24a3 adenoid cystic carcinoma , familial hyperinsulinemic hypoglycemia 1 , Salivary Gland Neoplasms Slc24a4 achondrogenesis type IA , amelogenesis imperfecta , amelogenesis imperfecta hypomaturation type 2A5 , genetic disease , Skin/Hair/Eye Pigmentation, Variation In, 6 Slc24a5 Bloom syndrome , colorectal cancer , genetic disease , Marfan syndrome , ocular albinism 1 , oculocutaneous albinism , oculocutaneous albinism type VI , Skin/Hair/Eye Pigmentation, Variation In, 4 Slc8a1 Alzheimer's disease , brain ischemia , Cardiomegaly , congestive heart failure , Diabetic Cardiomyopathies , dilated cardiomyopathy , Experimental Diabetes Mellitus , hypertension , Lynch syndrome , megacolon , Myocardial Ischemia , Myocardial Reperfusion Injury , Neurodevelopmental Disorders , pulmonary hypertension , Reperfusion Injury , status epilepticus Slc8a2 Alzheimer's disease , brain ischemia , Reperfusion Injury , status epilepticus Slc8a3 Alzheimer's disease , brain ischemia , prostate cancer , Reperfusion Injury , status epilepticus Slc8b1 Cerebral Hemorrhage Stim1 colorectal cancer , common variable immunodeficiency 10 , congenital structural myopathy , delta beta-thalassemia , developmental and epileptic encephalopathy , early infantile epileptic encephalopathy , esophagus squamous cell carcinoma , Experimental Neoplasms , gastrointestinal stromal tumor , genetic disease , hepatocellular carcinoma , hypertension , immunodeficiency 10 , juvenile rheumatoid arthritis , lung cancer , Lung Neoplasms , lung non-small cell carcinoma , migraine , Neointima , Neoplasm Metastasis , nephrogenic diabetes insipidus , stomach cancer , Stormorken syndrome , Tubular Aggregate Myopathies , tubular aggregate myopathy 1 , Vacuolar Myopathy Stim2 Weight Gain Tpcn1 oligospermia Tpcn2 Aicardi-Goutieres Syndrome 3 , brain infarction , intellectual disability , Marfanoid Mental Retardation Syndrome, Autosomal , Recurrent Infections, with Encephalopathy, Hepatic Dysfunction, and Cardiovascular Malformations , Skin/Hair/Eye Pigmentation, Variation In, 10 Trpv5 gestational diabetes , pre-eclampsia Trpv6 genetic disease , gestational diabetes , Hereditary Pancreatitis , hyperparathyroidism , polycystic ovary syndrome , pre-eclampsia , Transient Neonatal Hyperparathyroidism
1q24 Deletion Syndrome Cacna1e 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Atp2b2 abdominal obesity-metabolic syndrome 1 Atp2a2 achondrogenesis type IA Slc24a4 achromatopsia Cnga3 , Cngb3 Achromatopsia 1 Cnga3 , Cngb3 achromatopsia 2 Cnga3 achromatopsia 3 Cngb3 acrodermatitis Itpr3 acrokeratosis verruciformis Atp2a2 Acute Experimental Pancreatitis Atp2a2 acute kidney failure Mcoln1 acute stress disorder Cacna1c Adams-Oliver Syndrome 5 Cacna1b adenoid cystic carcinoma Slc24a3 adenoma Atp2a3 , Atp2b3 , Cacna1d adenylosuccinase lyase deficiency Cacna1i adrenal cortical adenoma Atp2b3 adrenoleukodystrophy Atp2b3 agenesis of the corpus callosum with peripheral neuropathy Atp2b2 Aicardi-Goutieres Syndrome 3 Tpcn2 Aicardi-Goutieres Syndrome 4 Cacna1a Aland Island eye disease Cacna1f alcohol dependence Cacna1c Alcohol Myopathy Atp2a1 Alcohol Withdrawal Seizures Cacna1d alkaptonuria Atp2c1 alpha-mannosidosis Cacna1a Alzheimer's disease Cacna1c , Itpr1 , Slc8a1 , Slc8a2 , Slc8a3 amelogenesis imperfecta Slc24a4 amelogenesis imperfecta hypomaturation type 2A5 Slc24a4 amenorrhea Ryr3 amyloidosis Cacna1c amyotrophic lateral sclerosis Cacna1a , Itpr2 Animal Disease Models Cacna1d , Itpr3 ankyloglossia Ryr1 anterior segment dysgenesis Itpr1 , Ryr1 anterior segment dysgenesis 7 Ryr1 anxiety disorder Cacna1c Aortic Coarctation Ryr1 arrhythmogenic right ventricular cardiomyopathy Cacna1c , Cacnb2 , Ryr2 arrhythmogenic right ventricular dysplasia 1 Ryr2 arrhythmogenic right ventricular dysplasia 9 Ryr2 arteriovenous malformations of the brain Cacna1h arthrogryposis multiplex congenita Ryr1 , Ryr3 asthma Itpr1 Ataxia Cacna1a , Cacnb4 , Itpr1 atrial heart septal defect Ryr1 Atrioventricular Septal Defect 2 Atp2b2 attention deficit hyperactivity disorder Cacna1a Auditory Neuropathy Cacna1a autism spectrum disorder Cacna1a , Cacna1c , Cacna1d , Cacnb2 , Itpr3 , Ryr2 autistic disorder Atp2b1 , Atp2b3 , Cacna1a , Cacna1c , Cacna1f , Cacna1h , Cnga2 , Itpr3 autosomal dominant cerebellar ataxia Itpr1 autosomal dominant intellectual developmental disorder 26 Ryr1 autosomal dominant intellectual developmental disorder 30 Atp2b1 autosomal dominant intellectual developmental disorder 5 Itpr3 Autosomal Dominant Intellectual Developmental Disorder 66 Atp2b1 autosomal dominant intellectual developmental disorder 8 Cacna1b autosomal dominant nonsyndromic deafness Atp2b2 autosomal dominant nonsyndromic deafness 82 Atp2b2 autosomal hemophilia A Atp2b3 , Cnga2 autosomal recessive chronic granulomatous disease 2 Cacna1e autosomal recessive nonsyndromic deafness 12 Atp2b2 Axial Myopathy, Late-Onset Ryr1 Bardet-Biedl syndrome Cngb1 Barth syndrome Atp2b3 beta thalassemia Cacna1h bipolar disorder Cacna1c , Cacna1d Bloom syndrome Ryr3 , Slc24a1 , Slc24a5 bone marrow disease Cacna1a Boucher-Neuhauser syndrome Mcoln1 Bradycardia Cacna1d brain disease Cacna1g brain edema Cacna1b Brain Hypoxia Itpr1 , Itpr2 brain infarction Atp2b2 , Tpcn2 brain ischemia Slc8a1 , Slc8a2 , Slc8a3 branched-chain keto acid dehydrogenase kinase deficiency Orai3 breast ductal carcinoma Cacna1c , Cacna1h Brody myopathy Atp2a1 Bronchomalacia Ryr1 Brugada syndrome Cacna1c , Cacnb2 , Ryr2 Brugada syndrome 3 Cacna1c Brugada syndrome 4 Cacnb2 Cachexia Atp2a1 , Atp2a2 cardiac arrest Cacnb2 , Itpr1 , Ryr2 Cardiac Arrhythmias Cacna1c , Cacnb2 , Ryr2 Cardiac Conduction Defect Ryr2 Cardiomegaly Atp2a2 , Itpr2 , Slc8a1 cardiomyopathy Cacna1c , Cacnb2 , Ryr1 , Ryr2 cataract Atp2b1 catecholaminergic polymorphic ventricular tachycardia Cacna1c , Ryr2 catecholaminergic polymorphic ventricular tachycardia 1 Ryr2 catecholaminergic polymorphic ventricular tachycardia 2 Ryr2 caudal regression syndrome Ryr1 centronuclear myopathy Cacna1s , Ryr1 cerebellar ataxia Cacna1a , Cacna1g , Itpr1 cerebellar ataxia type 42 Cacna1g cerebral creatine deficiency syndrome 1 Atp2b3 Cerebral Hemorrhage Slc24a1 , Slc8b1 cerebral palsy Cacna1a , Cacna1c cerebral venous thrombosis Cacna1a Charcot-Marie-Tooth disease dominant intermediate B Cacna1a Charcot-Marie-Tooth Disease Type 1J Itpr3 Chemical and Drug Induced Liver Injury Itpr1 childhood absence epilepsy Cacna1a , Cacna1h Childhood Absence Epilepsy 6 Cacna1h childhood electroclinical syndrome Cacna1a Childhood Schizophrenia Ryr2 chromosome 16p11.2 deletion syndrome, 220-kb Atp2a1 chromosome 16p11.2 deletion syndrome, 593-kb Atp2a1 Chromosome 16q12 Duplication Syndrome Cngb1 clubfoot Atp2b1 , Ryr1 Cognitive Dysfunction Cacna1c colon adenocarcinoma Cacna1d colon adenoma Cacna1d color blindness Cnga3 , Cngb3 colorectal cancer Ryr3 , Slc24a1 , Slc24a5 , Stim1 Coma Cacna1e combined immunodeficiency Cacna1a combined T cell and B cell immunodeficiency Cacna1a common variable immunodeficiency 10 Stim1 cone dystrophy Cnga3 cone-rod dystrophy Cacna1f , Cnga1 , Cnga3 , Cngb3 congenital disorder of glycosylation Iw Cacna1d congenital disorder of glycosylation type IIm Cacna1f congenital heart disease Ryr2 Congenital Hip Dislocation Ryr1 Congenital Limb Deformities Cacna1c congenital muscular dystrophy Ryr1 congenital myasthenic syndrome Ryr1 congenital myasthenic syndrome 12 Ryr1 Congenital Mydriasis Itpr1 congenital myopathy Ryr1 congenital myopathy 18 Cacna1s congenital myopathy 1A Ryr1 congenital myopathy 1B Ryr1 congenital myopathy 20 Ryr3 congenital myopathy 4A Ryr1 Congenital Neuromuscular Disease, with Uniform Type 1 Fiber Ryr1 congenital stationary night blindness Cacna1f , Slc24a1 congenital stationary night blindness 1D Slc24a1 congenital stationary night blindness 2A Cacna1f congenital stationary night blindness autosomal dominant 2 Slc24a1 congenital structural myopathy Orai1 , Ryr1 , Stim1 congestive heart failure Atp2a1 , Atp2a2 , Cacna1c , Ryr1 , Ryr2 , Slc8a1 Contracture Ryr3 Corneal Opacity Mcoln1 coronary artery disease Atp2b1 , Ryr2 Darier Disease, Acral Hemorrhagic Type Atp2a2 Darier Disease, Segmental Atp2a2 Deafness Cacna1d delta beta-thalassemia Stim1 developmental and epileptic encephalopathy Cacna1e , Cngb1 , Ryr3 , Stim1 developmental and epileptic encephalopathy 1 Cacna1a developmental and epileptic encephalopathy 14 Cacna1b developmental and epileptic encephalopathy 2 Cacna1a developmental and epileptic encephalopathy 42 Cacna1a developmental and epileptic encephalopathy 52 Cacna1a developmental and epileptic encephalopathy 69 Cacna1e Developmental Disabilities Atp2b3 , Cacna1a , Cacna1i , Ryr1 Developmental Disease Cacna1g diabetes mellitus Itpr1 Diabetic Cardiomyopathies Atp2a2 , Ryr2 , Slc8a1 Diabetic Nephropathies Cacna1b Diastolic Dysfunction Ryr2 dilated cardiomyopathy Atp2a1 , Cacna1c , Cacnb2 , Cacnb4 , Itpr1 , Orai3 , Ryr2 , Slc8a1 dilated cardiomyopathy 1AA Ryr2 dilated cardiomyopathy 1B Ryr2 Dilated Cardiomyopathy with Left Ventricular Noncompaction Ryr2 disorder of sexual development Cacna1a distal arthrogryposis Ryr1 Drug-Induced Dyskinesia Cacna1d Drug-Related Side Effects and Adverse Reactions Cacna1h Dwarfism Ryr1 Dysarthria Cacna1a dyskeratosis congenita Atp2b3 Dyskinesias Ryr1 dystonia Atp2b4 , Ryr1 dystonia 23 Cacna1b early infantile epileptic encephalopathy Cacna1e , Cngb1 , Stim1 Emery-Dreifuss muscular dystrophy Atp2b3 epilepsy Cacna1a , Cacna1b , Cacna1c , Cacna1d , Cacna1g , Cacna1h , Itpr1 , Ryr3 episodic ataxia Cacna1a , Cacnb4 episodic ataxia type 2 Cacna1a episodic ataxia type 5 Cacnb4 esophageal atresia Cacna1c esophagus squamous cell carcinoma Stim1 essential hypertension Atp2a2 euthyroid sick syndrome Atp2a2 exfoliation syndrome Cacna1a Experimental Autoimmune Encephalomyelitis Cacna1b Experimental Diabetes Mellitus Atp2a1 , Atp2a2 , Atp2a3 , Ryr2 , Slc8a1 Experimental Neoplasms Stim1 Eye Abnormalities Cacna1f , Cnga3 , Cngb3 factor VIII deficiency Atp2b3 , Cnga2 familial adult myoclonic epilepsy 5 Atp2b4 , Cacna1s familial hemiplegic migraine Cacna1a familial hemiplegic migraine 1 Cacna1a familial hemophagocytic lymphohistiocytosis 5 Mcoln1 Familial Hyperaldosteronism, Type IV Cacna1h familial hyperinsulinemic hypoglycemia 1 Slc24a3 familial hypertrophic cardiomyopathy Ryr2 Familial Sudden Death Ryr2 Familial Ventricular Tachycardia Cacna1c , Ryr2 favism Atp2b3 fetal akinesia deformation sequence syndrome Ryr1 fetal akinesia deformation sequence syndrome 1 Atp2b3 , Ryr1 , Ryr3 Fetal Growth Retardation Cacna1c , Cacna1d focal epilepsy Cacna1h fundus dystrophy Cacna1f , Cnga1 , Cnga3 , Cngb1 , Cngb3 , Slc24a1 gastroesophageal reflux disease Ryr1 gastrointestinal stromal tumor Atp2b4 , Cacna1e , Cacna1s , Ryr2 , Stim1 generalized dystonia Cacna1a Generalized Epilepsy Atp2b2 , Cacna1a , Cacnb4 , Ryr3 generalized epilepsy with febrile seizures plus 9 Orai3 genetic disease Atp2a1 , Atp2a2 , Atp2b1 , Atp2b3 , Atp2c1 , Cacna1a , Cacna1c , Cacna1d , Cacna1e , Cacna1f , Cacna1g , Cacna1h , Cacna1s , Cnga1 , Cnga3 , Cngb1 , Cngb3 , Itpr1 , Mcoln1 , Orai1 , Ryr1 , Ryr3 , Slc24a1 , Slc24a4 , Slc24a5 , Stim1 , Trpv6 Genetic Predisposition to Disease Cacna1c gestational diabetes Atp2b1 , Atp2b2 , Atp2b3 , Atp2b4 , Itpr1 , Itpr2 , Itpr3 , Ryr1 , Ryr2 , Ryr3 , Trpv5 , Trpv6 Gillespie syndrome Itpr1 glaucoma Ryr1 globe disease Cngb3 glutaric acidemia I Cacna1a glycoproteinosis Mcoln1 GNE myopathy Ryr1 Growth Disorders Mcoln1 Hailey-Hailey disease Atp2c1 Hearing Loss Atp2b2 , Cacna1d Heart Block Cacna1c , Cacna1d , Ryr1 , Ryr2 heart conduction disease Cacnb2 heart disease Atp2a2 , Ryr2 Heat Stroke Ryr1 hepatocellular carcinoma Ryr3 , Stim1 hereditary breast ovarian cancer syndrome Cacna1g Hereditary Leiomyomatosis and Renal Cell Cancer Ryr2 hereditary neuropathy with liability to pressure palsies Cacna1s hereditary nonpolyposis colorectal cancer type 5 Ryr1 Hereditary Pancreatitis Trpv6 hereditary spastic paraplegia Mcoln1 hereditary spastic paraplegia 39 Mcoln1 hereditary spastic paraplegia 5A Mcoln1 Huntington's disease Itpr1 hydrocephalus Cacna1i Hydrops Fetalis Ryr1 , Ryr3 Hyperalgesia Cacna1b , Cacna1h , Cacna1i , Itpr1 hyperglycemia Cacna1e hyperparathyroidism Trpv6 Hyperphosphatemic Familial Tumoral Calcinosis 1 Cacna1c hypertension Atp2a3 , Atp2b1 , Atp2b3 , Cacna1c , Cacnb2 , Orai1 , Slc8a1 , Stim1 hypertrophic cardiomyopathy Cacna1c , Cacnb2 , Ryr2 hypertrophic cardiomyopathy 1 Cacna1c , Ryr2 hypertrophic cardiomyopathy 4 Ryr2 hypoglycemia Cacna1c hypokalemic periodic paralysis Cacna1s Hypokalemic Periodic Paralysis, Type 1 Atp2b4 , Cacna1s hypoparathyroidism-deafness-renal disease syndrome Cacnb2 hypothyroidism Atp2a2 Hypoxia Itpr1 idiopathic generalized epilepsy Cacna1h , Cacnb4 idiopathic generalized epilepsy 9 Cacnb4 Imerslund-Grasbeck Syndrome Cacnb2 immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome Cacna1f immunodeficiency 10 Stim1 immunodeficiency 21 Atp2c1 immunodeficiency 33 Atp2b3 immunodeficiency 9 Orai1 Infant Death Ryr2 intellectual disability Cacna1a , Cacna1c , Cacna1d , Cacna1e , Cacna1g , Itpr1 , Itpr2 , Mcoln1 , Tpcn2 intracranial vasospasm Ryr1 invasive ductal carcinoma Cacna1c , Cacna1h Iron Overload Atp2a2 isolated anhidrosis with normal sweat glands Itpr2 isolated elevated serum creatine phosphokinase levels Ryr1 Joint Instability Cacna1c Joubert syndrome 1 Cacna1b juvenile myoclonic epilepsy Cacna1g , Cacnb4 juvenile rheumatoid arthritis Stim1 Kabuki syndrome Cacnb3 keratosis follicularis Atp2a2 King Denborough syndrome Ryr1 Kleefstra syndrome 1 Cacna1b Lambert-Eaton myasthenic syndrome Cacna1a , Cacna1b Language Development Disorders Cacna1c Lead Poisoning Ryr1 learning disability Cacna1a , Ryr1 Leber congenital amaurosis Cngb3 , Ryr2 Left Ventricular Hypertrophy Cacna1g , Ryr1 left ventricular noncompaction Ryr2 Lisch epithelial corneal dystrophy Mcoln1 long QT syndrome Cacna1c , Cacna1d , Cacna1i , Cacna1s , Cacnb2 , Itpr3 , Ryr1 , Ryr2 long QT syndrome 1 Cacna1c , Ryr2 long QT syndrome 8 Cacna1c lung cancer Stim1 Lung Neoplasms Stim1 lung non-small cell carcinoma Stim1 Lynch syndrome Slc8a1 macular degeneration Cacna1f , Cnga1 , Cnga3 , Cngb3 major depressive disorder Cacna1c Malignant Fever Cacna1s , Ryr1 malignant hyperthermia Cacna1s , Ryr1 Malignant Hypothermia Ryr1 malignant mesothelioma Ryr2 Marfan syndrome Slc24a5 Marfanoid Mental Retardation Syndrome, Autosomal Tpcn2 Marshall-Smith syndrome Cacna1a Meester-Loeys syndrome Atp2b3 megacolon Slc8a1 Memory Disorders Cacna1d Meniere's disease Cacna1d migraine Cacna1a , Stim1 migraine with aura Cacna1a Mitochondrial Progressive Myopathy with Congenital Cataract, Hearing Loss, and Developmental Delay Ryr1 Monomelic Amyotrophy Ryr3 movement disease Itpr1 mucolipidosis Mcoln1 mucolipidosis type IV Mcoln1 mucosulfatidosis Itpr1 multiple sclerosis Cacna1b Muscle Hypotonia Atp2b3 , Ryr1 Muscle Spasticity Cacna1a muscle tissue disease Ryr1 Muscle Weakness Cacna1a , Ryr1 muscular atrophy Cacna1s Myalgia Ryr1 myelitis Cacna1a myocardial infarction Ryr1 Myocardial Ischemia Ryr2 , Slc8a1 Myocardial Reperfusion Injury Atp2a1 , Atp2a2 , Slc8a1 myocardial stunning Atp2a2 Myoclonic Epilepsies Atp2b2 myoclonic-atonic epilepsy Atp2b2 , Cacna1a myopathy Ryr1 myopia Cacna1f Myotonia Ryr1 nemaline myopathy 2 Cacnb4 nemaline myopathy 6 Slc24a1 Neointima Atp2a2 , Stim1 Neoplasm Metastasis Orai1 , Stim1 nephrogenic diabetes insipidus Stim1 nephrotoxicity Cacna1g , Cacna1s , Itpr1 , Ryr1 Nerve Injuries Cacnb2 , Cacnb3 Nervous System Malformations Cacna1a , Mcoln1 neurodegeneration with brain iron accumulation 5 Cacna1f neurodegenerative disease Itpr1 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Cacna1c neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures Cacna1a , Cacna1c Neurodevelopmental Disorder with Seizures and Nonepileptic Hyperkinetic Movements Cacna1b Neurodevelopmental Disorder with Speech Impairment and with or without Seizures Cacna1i Neurodevelopmental Disorders Atp2b1 , Atp2b2 , Atp2b3 , Cacna1a , Cacna1c , Cacna1g , Itpr1 , Slc8a1 neurogenic bladder Cacna1a Neurologic Gait Disorders Cacna1a neuromuscular disease Ryr1 neuronal ceroid lipofuscinosis Atp2a1 , Cnga4 Niemann-Pick disease type A Itpr1 obesity Ryr1 obstructive sleep apnea Ryr1 ocular albinism 1 Slc24a5 oculocutaneous albinism Slc24a5 oculocutaneous albinism type VI Slc24a5 oligospermia Tpcn1 osteochondrodysplasia Ryr1 osteogenesis imperfecta type 1 Ryr1 osteoporosis Ryr1 ovarian cyst Cacnb3 panhypopituitarism Ryr1 paraplegia Atp2b3 parathyroid carcinoma Atp2b4 , Cacna1e , Cacna1s , Ryr2 Paroxysmal Ventricular Fibrillation Cacnb2 , Ryr2 pathologic nystagmus Cngb3 peripheral nervous system disease Cacna1b , Cacna1h periventricular leukomalacia Mcoln1 periventricular nodular heterotopia Atp2b3 persistent fetal circulation syndrome Atp2c2 pleomorphic xanthoastrocytoma Orai2 polycystic ovary syndrome Trpv6 post-traumatic stress disorder Cacna1c pre-eclampsia Atp2b1 , Atp2b2 , Atp2b3 , Atp2b4 , Itpr1 , Itpr2 , Itpr3 , Ryr1 , Ryr2 , Ryr3 , Trpv5 , Trpv6 Presbycusis Cacna1d Primary Aldosteronism, Seizures, and Neurologic Abnormalities Cacna1d primary coenzyme Q10 deficiency 7 Cacna1b primary hyperaldosteronism Atp2b3 , Cacna1d , Cacna1h primary immunodeficiency disease Cacna1c Primary Lymphedema with Myelodysplasia Atp2c1 primary ovarian insufficiency Ryr3 primary pulmonary hypertension Ryr1 progressive bulbar palsy Cacna1a prostate cancer Atp2b4 , Cacna1d , Cnga1 , Slc8a3 Prostatic Neoplasms Itpr1 proteasome-associated autoinflammatory syndrome 1 Itpr3 Psychomotor Agitation Cacna1c ptosis Ryr1 pulmonary hypertension Atp2a2 , Ryr1 , Ryr2 , Ryr3 , Slc8a1 pulmonary valve stenosis Cacna1c Rafiq syndrome Cacna1b Recurrent Infections, with Encephalopathy, Hepatic Dysfunction, and Cardiovascular Malformations Tpcn2 renal cell carcinoma Ryr1 Reperfusion Injury Slc8a1 , Slc8a2 , Slc8a3 respiratory failure Cacna1s , Ryr1 restrictive cardiomyopathy Cacna1c retinitis pigmentosa Cacna1f , Cnga1 , Cngb1 , Cngb3 , Slc24a1 retinitis pigmentosa 45 Cngb1 retinitis pigmentosa 49 Cnga1 , Cngb1 Rhabdomyolysis Cacna1s , Ryr1 rigid spine muscular dystrophy 1 Ryr1 Romano-Ward Syndrome Cacna1c Rubinstein-Taybi syndrome Cacna1i Salivary Gland Neoplasms Slc24a3 schizophrenia Atp2a1 , Cacna1c , Cacna1i sciatic neuropathy Cacna1d , Cacna1h , Cacna1i scoliosis Ryr1 Sepsis Atp2a1 , Cacna1s , Ryr1 severe congenital encephalopathy due to MECP2 mutation Atp2b3 short chain acyl-CoA dehydrogenase deficiency Orai1 short QT syndrome Cacna1c , Cacnb2 short-rib thoracic dysplasia 9 with or without polydactyly Cacna1h sick sinus syndrome Cacna1d Sinoatrial Node Dysfunction and Deafness Cacna1d Skin/Hair/Eye Pigmentation, Variation In, 10 Tpcn2 Skin/Hair/Eye Pigmentation, Variation In, 4 Slc24a5 Skin/Hair/Eye Pigmentation, Variation In, 6 Slc24a4 spastic ataxia Atp2b3 , Cacna1a , Cacna1g , Cacnb4 , Itpr1 Spastic Paraparesis Cacna1a Spinal Cord Injuries Atp2a1 , Atp2a2 , Ryr1 Spinocerebellar Ataxia 42, Early-Onset, Severe, with Neurodevelopmental Deficits Cacna1g spinocerebellar ataxia type 15 Itpr1 spinocerebellar ataxia type 29 Itpr1 spinocerebellar ataxia type 6 Cacna1a Spinocerebellar Ataxias Cacna1a , Cacna1g , Itpr1 Splenomegaly Atp2b3 Sporadic Hemiplegic Migraine Cacna1a Stargardt disease Cngb3 Stargardt Disease 1 Cngb3 status epilepticus Atp2a2 , Slc8a1 , Slc8a2 , Slc8a3 stomach cancer Stim1 Stormorken syndrome Stim1 subependymal giant cell astrocytoma Cacna1a Sudden Cardiac Death Cacna1c , Ryr2 Sudden Death Cacna1c , Cacnb2 , Ryr2 sudden infant death syndrome Cacna1a Sudden Unexpected Nocturnal Death Syndrome Cacna1c , Cacnb2 Supraventricular Tachycardia Cacna1d , Cacnb2 Syncope Ryr2 syndromic X-linked intellectual disability Lubs type Atp2b3 , Cacna1f , Cnga2 Tachycardia Ryr2 temporal lobe epilepsy Cacna1a thoracic aortic aneurysm Atp2b3 Thrombocytopenia 1 Cacna1f Thyrotoxic Periodic Paralysis Cacna1s Timothy syndrome Cacna1c transient cerebral ischemia Itpr1 Transient Neonatal Hyperparathyroidism Trpv6 Tremor Atp2b3 , Cacna1a , Cacna1c trichodontoosseous syndrome Cacna1g tuberous sclerosis 2 Cacna1h Tubular Aggregate Myopathies Orai1 , Stim1 tubular aggregate myopathy 1 Orai1 , Stim1 tubular aggregate myopathy 2 Orai1 type 1 diabetes mellitus Itpr3 type 2 diabetes mellitus Atp2a1 , Atp2a2 , Atp2a3 , Cacna1d Uncombable Hair Syndrome 1 Ryr1 Vacuolar Myopathy Stim1 Van der Woude syndrome Cacna1e vascular dementia Cacna1a Ventricular Dysfunction, Left Atp2a2 Ventricular Fibrillation Cacnb2 , Ryr2 Ventricular Fibrillation, Paroxysmal Familial, 1 Cacna1c , Ryr2 ventricular septal defect Ryr1 Ventricular Tachycardia Atp2a2 , Cacna1c , Cacnb2 , Ryr2 Ventriculomegaly Cacna1i Weight Gain Stim2 Wiskott-Aldrich syndrome Cacna1f withdrawal disorder Cacna1i Wolff-Parkinson-White syndrome Cacna1c , Cacna1e , Ryr2 X-linked cone-rod dystrophy 3 Cacna1f X-linked epilepsy with variable learning disabilities and behavior disorders Cacna1f X-linked severe congenital neutropenia Cacna1f X-linked spinocerebellar ataxia 1 Atp2b3